Jazz Pharmaceuticals plc Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Jazz Pharmaceuticals plc quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2024.
  • Jazz Pharmaceuticals plc Other Assets, Current for the quarter ending September 30, 2024 was $354M, a 14.1% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $354M +$43.8M +14.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $326M +$53.4M +19.6% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $315M +$69.3M +28.3% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $321M +$53.6M +20.1% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $310M +$60.4M +24.2% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $272M +$16.9M +6.63% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $245M +$1.36M +0.56% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $267M +$14.8M +5.86% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $250M +$24.9M +11.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $256M +$55.3M +27.6% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $244M +$96.2M +65.1% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $252M +$99.9M +65.5% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $225M +$97.8M +76.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $200M +$87.5M +77.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $148M +$53.4M +56.7% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $152M +$73.6M +93.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $127M +$45.9M +56.3% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $113M +$37.3M +49.5% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $94.3M +$31.3M +49.7% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $78.9M +$11.3M +16.8% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $81.4M +$27.1M +49.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $75.4M +$19.7M +35.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $63M +$117K +0.19% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $67.6M -$9.11M -11.9% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $54.3M +$5.19M +10.6% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $55.6M +$19.2M +52.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $62.9M +$35.8M +132% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $76.7M +$47.4M +162% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $49.1M +$24.6M +100% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $36.4M +$10.2M +38.9% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $27.1M +$4.62M +20.6% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $29.3M +$10.3M +53.9% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $24.5M +$5.55M +29.2% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $26.2M +$4.26M +19.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $22.4M +$909K +4.22% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $19M -$2.28M -10.7% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $19M +$607K +3.31% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $22M +$3.52M +19% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $21.5M -$2.23M -9.37% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $21.3M -$12.5M -37% Dec 31, 2014 10-K 2016-02-23
Q3 2014 $18.4M -$189K -1.02% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $18.5M -$1.25M -6.33% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $23.7M +$2.35M +11% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $33.8M +$14.7M +77.1% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $18.6M +$8.61M +86.6% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $19.7M +$6.21M +46% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $21.4M +$17.3M +425% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $19.1M +$17.9M +1417% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $9.94M +$9.41M +1769% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $13.5M +$13.1M +3436% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $4.07M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $1.26M +$981K +352% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $532K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $382K Jun 30, 2011 10-Q 2011-08-03
Q4 2010 $279K Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.